Blood thinners for heart clots in atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have atrial fibrillation (irregular heartbeat) confirmed by an ECG or Holter monitor.
- An ultrasound of your heart (transesophageal echocardiogram) shows a clot inside your heart.
- You have not taken any blood thinners for this clot yet.
- You do not have heart valve disease or other conditions that increase bleeding risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.
This study compares two ways to manage atrial fibrillation (an irregular heartbeat) in people on dialysis. One approach uses a blood thinner called apixaban, and the other does not use blood thinners. The goal is to see which approach better prevents strokes and bleeding.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.